MVM Life Science Partners LLP

MVM has invested in high-growth healthcare businesses since 1997, with a broad, global investment outlook spanning medical technology, pharmaceuticals, diagnostics, contract research and manufacturing, digital health, and other sectors of healthcare. MVM collaborates with best-in-class management teams to bring innovative products to market, drive growth, make strategic acquisitions, and establish new standards of care in medicine. MVM seeks out portfolio companies that address significant unmet needs in large addressable markets — including medical conditions for which there is no adequate treatment, therapies for which existing technologies are too expensive, or diseases for which there is no accurate diagnostic capability. The firm prioritizes businesses with clearly differentiated technology and durable protection against competition, whether through intellectual property, barriers to market entry, statutory exclusivity, or unique branding. MVM expects to make aggregate investments of $20 to $100 million per portfolio company over its holding period, maintaining a concentrated portfolio focused on building world-class companies.